Procurement Summary
Country: USA
Summary: Medicinal Chemistry Support for Therapeutic Development Synthesis of Hervk Protease Inhibitors
Deadline: 10 Aug 2026
Posting Date: 01 Aug 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 146373799
Document Ref. No.: 75N98026Q00906
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
COMBINED SYNOPSIS / SOLICITATION
Title: Medicinal Chemistry Support for Therapeutic Development: Synthesis of HERV-K Protease Inhibitors
This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
The solicitation number is 75N98026Q00906. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold of $350, 000.00.
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a Firm-Fixed-Price to the responsible offeror whose proposal represents the best value to the Government.
The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 March 13, 2026.
The associated NAICS code is 541380, and the small business size standard is N/A.
This requirement is NOT A SET-ASIDE for small businesses.
Description of Requirement:
Medicinal Chemistry
The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any agency-specific instructions as required.
The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.
The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation represents the best value to the Government, price and other fac...
Notice ID: 75n98026q00906
Department/Ind. Agency: health and human services, department of
Sub-tier: national institutes of health
Office: national institutes of health olao
Product Service Code: 6505 - drugs and biologicals
NAICS Code: 541380 - Testing Laboratories and Services
Inactive Dates: aug 25, 2026
Inactive Policy: 15 days after date offers due
Documents
Tender Notice